BIS vs PSQ
ProShares UltraShort NASDAQ Biotechnology against ProShares Short QQQ: cost, size, returns, what they hold and how much of it is the same.
Fee gap
0 bp
same fee
1-year return gap
32.9 pts
PSQ is ahead
Larger fund
PSQ
$641M
Side by side
| BIS | PSQ | |
|---|---|---|
| Fund | ProShares UltraShort NASDAQ Biotechnology | ProShares Short QQQ |
| Issuer | ProShares | ProShares |
| Category | Inverse Equity | Inverse Equity |
| Expense ratio | 0.95% | 0.95% |
| Assets | $1.9M | $641M |
| Average daily dollar volume | $125K | $617M |
| Listed | Apr 6, 2010 | Jun 19, 2006 |
| FrenzyCap score | 28 | 75 |
| 1-month return | +2.7% | +8.3% |
| 3-month return | +2.5% | +6.8% |
| Year to date | −39.9% | −8.1% |
| 1-year return | −43.4% | −10.5% |
| 30-day volatility | 60.1% | 30.4% |
| Worst drawdown, 1 year | −51.4% | −27.4% |
| Trailing 12-month yield | 3.92% | 3.74% |
| Holdings | 6 | 15 |
| Top 10 weight | 0.0% | 35.7% |
| Look-through P/E | — | — |
| Holdings vs fair value | — | — |
| Holdings above 200-day average | — | — |
| Net flow, latest 3 reported months | +$354K thru Aug 2026 | −$8.0M thru Aug 2026 |
| 30-day implied volatility | 57.8% | 28.4% |
| Holdings as of | as of Nov 18, 2026issuer data | as of Nov 18, 2026issuer data |
Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.
More: full overlap table · BIS holdings · PSQ holdings
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.